440 Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$852K Sell
10,084
-84
-0.8% -$7.15K 0.61% 45
2017
Q3
$870K Buy
10,168
+2,386
+31% +$196K 0.66% 43
2017
Q2
$640K Buy
7,782
+100
+1% +$8.16K 0.51% 49
2017
Q1
$646K Buy
+7,682
New +$615K 0.58% 44

Other funds holding LLY

440 Investment Group's LLY Position: Q4 2017 in Review

440 Investment Group reduced its Eli Lilly (LLY) stake by 0.83% in Q4 2017, selling an estimated $7.15K and leaving 10,084 shares worth $852K. The position accounts for 0.61% of the portfolio, ranked #45.

440 Investment Group first reported a position in LLY in Q1 2017 and has held it in 4 quarters since. The position peaked at $870K in Q3 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • 440 Investment Group held 10,084 shares of Eli Lilly worth $852K as of Q4 2017.
  • 440 Investment Group sold 84 Eli Lilly shares in Q4 2017, an estimated $7.15K.
  • Eli Lilly made up 0.61% of 440 Investment Group's portfolio in Q4 2017, its #45 holding.
  • 440 Investment Group first reported a position in Eli Lilly in Q1 2017 and has held it in 4 quarters since.
  • 440 Investment Group's Eli Lilly position peaked at $870K in Q3 2017.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on 440 Investment Group's 13F filing for Q4 2017, filed 16 Jan 2018.